Squarepoint Ops LLC - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 367 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 1.30 and the average weighting 0.2%.

Quarter-by-quarter ownership
Squarepoint Ops LLC ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,896,132
-60.8%
32,141
-63.0%
0.01%
-66.7%
Q2 2023$9,941,596
-28.3%
86,811
-13.7%
0.03%
-47.4%
Q1 2023$13,864,320
-48.2%
100,590
-51.3%
0.06%
-46.2%
Q4 2022$26,757,752
+70.3%
206,496
+45.3%
0.11%
+34.2%
Q3 2022$15,708,000
+76.7%
142,102
+19.8%
0.08%
+61.2%
Q2 2022$8,888,000
+10.8%
118,575
+15.4%
0.05%
+44.1%
Q1 2022$8,024,000
+171.4%
102,709
+212.9%
0.03%
+325.0%
Q4 2021$2,956,000
-35.2%
32,829
-46.3%
0.01%
-70.4%
Q1 2021$4,560,000
+1375.7%
61,187
+3271.2%
0.03%
+1250.0%
Q4 2020$309,000
-92.0%
1,815
-93.4%
0.00%
-96.2%
Q3 2020$3,864,000
-58.9%
27,513
-53.1%
0.05%
-65.8%
Q2 2020$9,407,000
+852.1%
58,666
+480.9%
0.15%
+508.0%
Q1 2020$988,000
-69.4%
10,100
-59.6%
0.02%
+31.6%
Q4 2019$3,227,000
+51.0%
25,004
+77.7%
0.02%
-9.5%
Q2 2019$2,137,000
-31.0%
14,067
-45.9%
0.02%
-36.4%
Q1 2019$3,097,000
-35.0%
25,982
-27.9%
0.03%
-47.6%
Q2 2018$4,766,000
+149.7%
36,055
+40.0%
0.06%
+110.0%
Q1 2018$1,909,000
+61.9%
25,760
+21.5%
0.03%
+42.9%
Q4 2017$1,179,000
-22.5%
21,198
-36.8%
0.02%
-27.6%
Q3 2017$1,522,000
+226.6%
33,546
+142.8%
0.03%
+222.2%
Q2 2017$466,000
-62.3%
13,815
-66.9%
0.01%
-73.5%
Q1 2017$1,236,000
-3.6%
41,773
-10.6%
0.03%
-34.6%
Q4 2016$1,282,00046,7380.05%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Perceptive Advisors 2,878,979$69,182,0007.27%
Eventide Asset Management 259,100$6,226,0000.97%
GLADE BROOK CAPITAL PARTNERS LLC 251,000$6,032,0000.93%
IMS Capital Management 32,215$774,0000.91%
Perceptive Advisors 350,000$8,413,0000.88%
Benchmark Capital Advisors 34,900$839,0000.58%
BECK CAPITAL MANAGEMENT, LLC 24,744$636,0000.49%
SABBY MANAGEMENT, LLC 352,100$8,461,0000.47%
Hatteras Alternative Mutual Funds, LLC 39,404$947,0000.46%
Potomac Capital Management, Inc. 22,100$531,0000.45%
View complete list of SAREPTA THERAPEUTICS INC shareholders